Eisai
Daniel B. serves as the Senior Medical Science Liaison for Eisai US, specializing in oncology for the NY/NJ region since September 2022. Prior to this role, Daniel B. held several positions at Bristol Myers Squibb from July 2015 to September 2022, including Associate Director of Field Medical Communications and Publications Manager focusing on biomarkers and gastrointestinal oncology. Daniel B.’s fellowship at Bristol Myers Squibb included experience in Medical Information and Data Operations, significantly contributing to drug launches and managing late-phase clinical trials. Additionally, Daniel B. has experience as an Adjunct Professor at Rutgers University and held various roles at the Coptic Orthodox Church, including IT support and coaching. Educational qualifications include a Doctor of Pharmacy and an MBA in Strategy & Leadership from Rutgers Business School.
This person is not in any teams
This person is not in any offices
Eisai
12 followers
Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical segment and other segment. The pharmaceutical segment is engaged in the research, develop, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The other segment consists of pharmaceutical raw materials, logistics services and business services businesses.